Wenting Yan

Southwest Hospital

Papers

1

Total Citations

50

H-Index

1

About

Dr. Wenting Yan is a leading surgical oncologist whose research is reshaping breast cancer treatment by rigorously evaluating the long-term outcomes of minimally invasive techniques. Her landmark 2022 study, “Association of Long-term Oncologic Prognosis With Minimal Access Breast Surgery vs Conventional Breast Surgery,” directly addressed a critical knowledge gap, providing the first robust evidence that minimal access breast surgery (MABS) offers comparable long-term prognostic safety to conventional approaches. Garnering 50 citations, this work has become a cornerstone for surgeons weighing oncologic efficacy against cosmetic benefits. Dr. Yan’s major contribution lies in moving the conversation beyond short-term recovery metrics to focus on survival and recurrence, thereby validating MABS as a standard-of-care option. Her research empowers patients with more choices without compromising outcomes, a significant achievement in patient-centered oncology. By bridging the gap between surgical innovation and long-term evidence, Dr. Yan is helping to define the future of breast cancer surgery, ensuring that less invasive procedures are backed by the same rigorous prognostic data as traditional methods.

Research Focus

Key Achievements

1
H-Index
1
Papers
50
Total Citations
50
Avg Citations/Paper
🏆 Most Cited Paper
Association of Long-term Oncologic Prognosis With Minimal Access Breast Surgery vs Conventional Breast Surgery
50 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: Southwest Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago